Tech Company Financing Transactions
Pulmonx Funding Round
On 5/11/2020, Pulmonx raised $66 million in financing from Ally Bridge Group, Adage Capital Management and HealthQuest Capital.
Transaction Overview
Company Name
Announced On
5/11/2020
Transaction Type
Venture Equity
Amount
$66,000,000
Round
Undisclosed
Investors
Ally Bridge Group (Lead Investor) (Frank Yu)
Proceeds Purpose
Proceeds from this financing will ensure that Pulmonx is well-capitalized to support the continued global commercial expansion of the Zephyr Valve System, the first FDA-approved minimally-invasive treatment option for severe emphysema, a form of COPD.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
700 Chesapeake Dr.
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
Pulmonx (Nasdaq: LUNG) is an innovative medical technology company engaged in the design, development and manufacture of therapeutic devices for the treatment of patients with severe emphysema.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Glen French
Chief Financial Officer
Martin Schneider
Chief Financial Officer
Derrick Sung
Chief Technical Officer
Sri Radhakrishnan
General Manager
Jérôme Erath
Vice President
Kelly Shriner
VP - Bus. Development
Beran Rose
VP - Finance
Lauren Cristina
VP - Regulatory Affairs
Narinder Shargill
VP - Sales
David Renzi
Browse more venture capital transactions:
Prev: 5/11/2020: Wellth venture capital transaction
Next: 5/11/2020: nextmv venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs